Andere Sprachen Precipio, Inc.

Aktien

A3ETCE

US74019L6020

PRPO

Verzögert Nasdaq Andere Börsenplätze 17:34:22 25.04.2024			% 5 Tage	% 1. Jan.
5,77 ^USD	-1,54 %		-6,94 %	-11,23 %

01.04.	Transcript : Precipio, Inc. - Special Call
29.03.	Precipio, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
Precipio Announces Year end 2023 Shareholder Update Call	25.03.
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY	13.02.
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer	06.02.
Precipio, Inc. and Cardinal Health Sign Distribution Agreement for Its HemeScreen®? Portfolio of Molecular Assays for Cancer	06.02.
Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter	23.01.
Sector Update: Health Care Stocks Slipping Late Afternoon	17.01.
Sector Update: Health Care Stocks Edge Down Wednesday Afternoon	17.01.
Precipio Signs Distribution Deal in Japan, Gets First Order; Shares Rise	17.01.
Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	17.01.
Precipio, Inc. Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	17.01.
Precipio Announces Christina Valauri joins the Board of Directors	02.01.
Precipio, Inc. Announces Board Changes	02.01.
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024	14.12.
North American Morning Briefing : Stocks Futures -2-	20.11.
Precipio Announces Q3-2023 Shareholder Update Call	16.11.
Precipio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022	18.10.23
Precipio, Inc. Reports Unaudited Revenue Results for the Third Quarter of 2023	18.10.23
Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023	03.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Precipio, Inc.

Aktien

A3ETCE

US74019L6020

PRPO

Andere Sprachen

Filter